Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Real-World CAR-T Utilization and Competing Mortality Following Covalent BTKi Therapy in Mantle Cell Lymphoma

MCL - 1460

Real-World CAR-T Utilization and Competing Mortality Following Covalent BTKi Therapy in Mantle Cell Lymphoma

Alexandra Miller

Poster Presenter: Alexandra Miller

Thumbnail for Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

HL - 1461

Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

Haroon Alamy

Poster Presenter: Haroon Alamy

Previous 1...117 118 119 120 121 122 123...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Primary Immune Thrombocytopenia: A Systematic Review and Meta-Analysis

CT - 1462

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Primary Immune Thrombocytopenia: A Systematic Review and Meta-Analysis

Arashdeep Singh

Poster Presenter: Arashdeep Singh

Thumbnail for Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

HL - 1463

Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

Olanipekun Lanny Ntukidem

Poster Presenter: Olanipekun Lanny Ntukidem

Thumbnail for Molecular Subtype-Specific Risk of Subsequent Acute Myeloid Leukemia Following Breast Cancer: A Population-Based SEER Analysis

AML - 1464

Molecular Subtype-Specific Risk of Subsequent Acute Myeloid Leukemia Following Breast Cancer: A Population-Based SEER Analysis

Maryam Ali

Poster Presenter: Maryam Ali

Thumbnail for Statin Exposure Is Associated With Improved Survival in Diffuse Large B-Cell Lymphoma: A Large Propensity Score-Matched Real-World Analysis

ABCL - 1468

Statin Exposure Is Associated With Improved Survival in Diffuse Large B-Cell Lymphoma: A Large Propensity Score-Matched Real-World Analysis

Fnu Ashvin Rajeev Pillai

Poster Presenter: Fnu Ashvin Rajeev Pillai

Thumbnail for Predictors and Inpatient Outcomes of Tumor Lysis Syndrome in Diffuse Large B-Cell Lymphoma Hospitalizations: A Nationwide Analysis, 2016-2020

ABCL - 1469

Predictors and Inpatient Outcomes of Tumor Lysis Syndrome in Diffuse Large B-Cell Lymphoma Hospitalizations: A Nationwide Analysis, 2016-2020

Srijani Thannir

Poster Presenter: Srijani Thannir

Thumbnail for Efficacy and Safety of CAR-T Cell Therapy in Plasma Cell Leukemia: A Systematic Review and Meta-Analysis

MM - 1470

Efficacy and Safety of CAR-T Cell Therapy in Plasma Cell Leukemia: A Systematic Review and Meta-Analysis

Summiya Nasim

Poster Presenter: Summiya Nasim

Thumbnail for Multiple Myeloma Mortality in the United States, 1968-2023, With Forecasts to 2050

MM - 1472

Multiple Myeloma Mortality in the United States, 1968-2023, With Forecasts to 2050

Haseeb Khan Tareen

Poster Presenter: Haseeb Khan Tareen

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors